Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Otitis Media | 3 | 2022 | 288 | 1.010 |
Why?
|
| Otitis Media with Effusion | 1 | 2022 | 115 | 0.760 |
Why?
|
| Otolaryngology | 4 | 2022 | 701 | 0.730 |
Why?
|
| Riboflavin | 1 | 2020 | 107 | 0.690 |
Why?
|
| Blood Component Transfusion | 1 | 2020 | 141 | 0.660 |
Why?
|
| Disease Transmission, Infectious | 2 | 2021 | 560 | 0.600 |
Why?
|
| Nasopharynx | 1 | 2020 | 420 | 0.560 |
Why?
|
| Plasma | 1 | 2020 | 585 | 0.550 |
Why?
|
| Cytoplasmic Granules | 1 | 2019 | 574 | 0.520 |
Why?
|
| Aerosols | 4 | 2021 | 636 | 0.480 |
Why?
|
| Middle Ear Ventilation | 3 | 2022 | 101 | 0.410 |
Why?
|
| Fluorescent Dyes | 1 | 2020 | 1933 | 0.400 |
Why?
|
| Stress, Physiological | 1 | 2019 | 1408 | 0.370 |
Why?
|
| Cell Culture Techniques | 1 | 2019 | 1667 | 0.370 |
Why?
|
| Emergency Medical Services | 1 | 2020 | 1947 | 0.310 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 2517 | 0.280 |
Why?
|
| Models, Biological | 2 | 2020 | 9499 | 0.240 |
Why?
|
| Pancreatic Neoplasms | 2 | 2022 | 5443 | 0.240 |
Why?
|
| Cadaver | 4 | 2021 | 1366 | 0.230 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2023 | 342 | 0.190 |
Why?
|
| Advanced Practice Nursing | 1 | 2021 | 18 | 0.190 |
Why?
|
| Endoscopy | 2 | 2021 | 1862 | 0.180 |
Why?
|
| Insurance | 1 | 2021 | 115 | 0.170 |
Why?
|
| Fluorescein | 1 | 2020 | 175 | 0.170 |
Why?
|
| Suction | 1 | 2021 | 268 | 0.170 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2020 | 139 | 0.170 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2020 | 119 | 0.160 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.140 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2023 | 493 | 0.140 |
Why?
|
| Glycomics | 1 | 2018 | 118 | 0.140 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 326 | 0.140 |
Why?
|
| Risk Adjustment | 1 | 2021 | 603 | 0.140 |
Why?
|
| Models, Anatomic | 1 | 2020 | 683 | 0.130 |
Why?
|
| Carbohydrates | 1 | 2018 | 389 | 0.130 |
Why?
|
| Particle Size | 1 | 2020 | 1652 | 0.130 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2017 | 348 | 0.120 |
Why?
|
| Pancreas | 1 | 2019 | 1700 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2017 | 1183 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2019 | 2635 | 0.090 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2022 | 1756 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 1640 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1769 | 0.090 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 2931 | 0.080 |
Why?
|
| Survival Rate | 1 | 2020 | 12873 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2018 | 3070 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 3116 | 0.050 |
Why?
|
| Infant | 2 | 2022 | 36556 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 10400 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 17173 | 0.050 |
Why?
|
| Humans | 12 | 2023 | 768970 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 9080 | 0.050 |
Why?
|
| Human papillomavirus 16 | 1 | 2023 | 268 | 0.050 |
Why?
|
| Obesity | 1 | 2022 | 13091 | 0.040 |
Why?
|
| Child | 3 | 2022 | 80960 | 0.040 |
Why?
|
| Hydrodynamics | 1 | 2020 | 167 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2021 | 565 | 0.040 |
Why?
|
| Craniofacial Abnormalities | 1 | 2021 | 320 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2023 | 2205 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 306 | 0.030 |
Why?
|
| Glycosylation | 1 | 2018 | 1101 | 0.030 |
Why?
|
| Hearing Loss | 1 | 2021 | 785 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15661 | 0.030 |
Why?
|
| Down Syndrome | 1 | 2021 | 919 | 0.030 |
Why?
|
| Intubation, Intratracheal | 1 | 2020 | 1359 | 0.020 |
Why?
|
| HIV Infections | 1 | 2018 | 17591 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 82072 | 0.020 |
Why?
|
| Linear Models | 1 | 2021 | 5891 | 0.020 |
Why?
|
| Acute Disease | 1 | 2021 | 7245 | 0.020 |
Why?
|
| Animals | 2 | 2019 | 169335 | 0.020 |
Why?
|
| Male | 4 | 2021 | 365203 | 0.020 |
Why?
|
| DNA | 1 | 2023 | 7214 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2021 | 24333 | 0.020 |
Why?
|
| Female | 4 | 2021 | 397515 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 223737 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 223851 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8513 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2017 | 2574 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2021 | 9384 | 0.020 |
Why?
|
| Research Design | 1 | 2021 | 6214 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4413 | 0.010 |
Why?
|
| Prevalence | 1 | 2021 | 15879 | 0.010 |
Why?
|
| Logistic Models | 1 | 2018 | 13318 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5522 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 19023 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 39394 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 22379 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 81903 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 89244 | 0.010 |
Why?
|
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_